telmisartan has been researched along with Cancer of Prostate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatia, RK; Chandra, R; Coutinho, EC; Jain, UK; Katare, OP; Kaur, M; Madan, J; Pissurlenkar, RR | 1 |
| Chen, LJ; Cheng, JT; Niu, HS; Tong, YC; Wu, TT | 1 |
| Azoulay, L; Bartels, DB; Dell'Aniello, S; Suissa, S; Tascilar, K | 1 |
| Chargui, J; Funao, K; Kawahito, Y; Matsuyama, M; Nakatani, T; Sano, H; Touraine, JL; Yoshimura, R | 1 |
| Debanne, SM; Fang, JC; Rowland, DY; Simon, DI; Sipahi, I | 1 |
| Ishiguro, H; Komiya, M; Kubota, Y; Long, N; Seeni, A; Shirai, T; Takahashi, S; Tang, M; Uemura, H | 1 |
| Ishiguro, H; Ishiguro, Y; Kubota, Y; Uemura, H | 1 |
1 review(s) available for telmisartan and Cancer of Prostate
| Article | Year |
|---|---|
Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Neoplasms; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk; Telmisartan | 2010 |
6 other study(ies) available for telmisartan and Cancer of Prostate
| Article | Year |
|---|---|
Telmisartan complex augments solubility, dissolution and drug delivery in prostate cancer cells.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Benzimidazoles; Benzoates; beta-Cyclodextrins; Cell Line, Tumor; Computer Simulation; Drug Carriers; Humans; Male; Models, Molecular; Molecular Conformation; Prostatic Neoplasms; Solubility; Telmisartan | 2014 |
Increase of human prostate cancer cell (DU145) apoptosis by telmisartan through PPAR-delta pathway.
Topics: Angiotensin II Type 1 Receptor Blockers; Antineoplastic Agents; Apoptosis; Benzimidazoles; Benzoates; Cell Line, Tumor; Humans; Male; PPAR delta; Prostatic Neoplasms; RNA Interference; RNA, Small Interfering; Sulfones; Telmisartan; Thiophenes | 2016 |
The Use of Telmisartan and the Incidence of Cancer.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Breast Neoplasms; Colorectal Neoplasms; Databases, Factual; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Prostatic Neoplasms; Risk Assessment; Risk Factors; Telmisartan; Time Factors; United Kingdom | 2016 |
Telmisartan is a potent target for prevention and treatment in human prostate cancer.
Topics: Angiotensin II Type 1 Receptor Blockers; Apoptosis; Benzimidazoles; Benzoates; Cell Proliferation; Flow Cytometry; Humans; Male; PPAR gamma; Prostate; Prostatic Neoplasms; Telmisartan; Tumor Cells, Cultured | 2008 |
Therapeutic targeting of angiotensin II receptor type 1 to regulate androgen receptor in prostate cancer.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Benzoates; Biphenyl Compounds; Cell Line, Tumor; Disease Models, Animal; Estrogen Receptor beta; Gene Expression Regulation, Neoplastic; Humans; Male; Molecular Targeted Therapy; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptors, Androgen; Telmisartan; Tetrazoles | 2012 |
Regulation of prostate cancer cell growth and PSA expression by angiotensin II receptor blocker with peroxisome proliferator-activated receptor gamma ligand like action.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Cell Division; Cell Line, Tumor; Genes, Reporter; Humans; Male; Mitogen-Activated Protein Kinases; PPAR gamma; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Telmisartan | 2007 |